Literature DB >> 529028

Regional and systemic serum concentrations of 5-fluorouracil after portal and intravenous infusion: an experimental study in dogs.

B G Gustavsson, A Brandberg, C G Regårdh, O E Almersjö.   

Abstract

The serum and urinary concentrations of 5-FU after continuous portal and jugular infusion have been followed by means of a highly sensitive microbiological assay method. Our data indicate that more than 90% of 5-FU was eliminated in the liver after continuous portal infusion of 0.625 mg x kg-1 x hr-1, corresponding to a dose of 15 mg x kg-1 x 24 hr-1. Negligible amounts of intact 5-FU were excreted into the bile, and the urinary excretion was only a few percent of the amount infused. The arterial concentration was on average tenfold higher during the continuous jugular infusion than after the continuous portal infusion, indicating that the route of administration has a pronounced effect on the disposition of 5-FU. Twenty-three percent of the jugular dose reached the liver; 77% was degraded by extrahepatic metabolism. Of these, degradation in the prehepatic splanchnic area accounted for 15%.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 529028     DOI: 10.1007/BF01061213

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  23 in total

1.  A LESS TOXIC FLUOROURACIL DOSAGE SCHEDULE.

Authors:  F J ANSFIELD
Journal:  JAMA       Date:  1964-11-16       Impact factor: 56.272

2.  Studies on fluorinated pyrimidines. IX. The degradation of 5-fluorouracil-6-C14.

Authors:  K L MUKHERJEE; C HEIDELBERGER
Journal:  J Biol Chem       Date:  1960-02       Impact factor: 5.157

3.  The physiological disposition of 5-fluorouracil in mice bearing solid L1210 lymphocytic leukemia.

Authors:  M Chadwick; W I Rogers
Journal:  Cancer Res       Date:  1972-05       Impact factor: 12.701

4.  Effect of glucagon on total liver blood flow in hemorrhagic shock.

Authors:  N Darle; R C Lim; F W Blaisdell
Journal:  Acta Chir Scand       Date:  1974

5.  The effect of prednisolone and other factors on the catabolism of 5-fluorouracil in rats.

Authors:  J J Ambre; L J Fischer
Journal:  J Lab Clin Med       Date:  1971-09

6.  The almost complete hepatic extraction of propranolol during intravenous administration in the dog.

Authors:  D G Shand; G H Evans; A S Nies
Journal:  Life Sci I       Date:  1971-12-15

7.  Further studies with topical 5-fluorouracil.

Authors:  C J Dillaha; G T Jansen; W M Honeycutt; G A Holt
Journal:  Arch Dermatol       Date:  1965-10

8.  Results of regional portal infusion of 5-fluorouracil in patients with primary and secondary liver cancer.

Authors:  O Almersjö; B Gustavsson; L Hafström
Journal:  Ann Chir Gynaecol       Date:  1976

9.  Decrease of oxygen consumption in the dog liver during temporary arterial occlusion.

Authors:  M Andreen; L Irestedt
Journal:  Acta Physiol Scand       Date:  1976-09

10.  Pharmacokinetic studies of 5-fluorouracil after oral and intravenous administration in man.

Authors:  O E Almersjö; B G Gustavsson; C G Regårdh; P Wåhlén
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1980-05
View more
  3 in total

1.  Cardiopulmonary hemodynamics and pharmacokinetics after hepatic intraarterial infusion of 5-fluorouracil (5-FU). An experimental study in the pig.

Authors:  M Andersson; L Domellöf; S Häggmark; G Johansson; S Reiz; B Gustavsson
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

2.  Clinical applicability of current pharmacokinetic models: splanchnic elimination of 5-fluorouracil in cancer patients.

Authors:  P J Robinson; L Bass; S M Pond; M S Roberts; J G Wagner
Journal:  J Pharmacokinet Biopharm       Date:  1988-06

3.  Effect of age on the disposition and tissue clearances of fluorinated pyrimidines in rats.

Authors:  J L Au
Journal:  Pharm Res       Date:  1985-11       Impact factor: 4.200

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.